This Article Full Text Full Text (PDF) All Versions of this Article: 2003-0050OCv1 30/1/101    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Potter-Perigo, S. Articles by Wight, T. N. Search for Related Content PubMed PubMed Citation Articles by Potter-Perigo, S. Articles by Wight, T. N.

Regulation of Proteoglycan Synthesis by Leukotriene D4 and Epidermal Growth Factor in Bronchial Smooth Muscle Cells

The Hope Heart Institute and Departments of Pathology and Medicine, Division of Allergy and Infectious Diseases, and School of Nursing, University of Washington, School of Medicine, Seattle, Washington

Address correspondence to: Thomas N. Wight, Ph.D., Department of Vascular Biology, The Hope Heart Institute, 1124 Columbia Street, Seattle, WA 98104. E-mail: twight{at}hopeheart.org

Extracellular matrix (ECM) expansion contributes to airway remodeling in asthma. This study examines the effect of leukotriene D4 (LTD4), combined with epidermal growth factor (EGF), on proteoglycan synthesis by cultured human bronchial smooth muscle cells (BSMCs). LTD4 plus EGF stimulated proliferation of BSMCs with increased versican synthesis. Further, versican mRNA splice variants, V0 and V1, were differently regulated in BSMCs by LTD4 plus EGF. Synthesis of [³⁵S]-methionine labeled versican V0, as a percentage of total versican, was doubled. This upregulation was confirmed by Western analysis. Synthetic changes were paralleled by alterations in versican V0 mRNA. The effects of LTD4 and EGF on proteoglycan synthesis were inhibited by montelukast. Similar upregulation of versican V0 was observed in arterial smooth muscle cells (ASMCs) stimulated with LTD4 plus EGF as measured by western and reverse transcriptase–polymerase chain reaction analyses. Changes in ECM in the asthmatic airway may parallel those in atherosclerotic lesions where proliferating ASMCs synthesize a versican-rich expanded ECM. Inhibition of these processes could lead to reduced tissue expansion in the early phases of asthma progression.

Abbreviations: arterial smooth muscle cell, ASMC • bronchial smooth muscle cell, BSMC • Dulbecco's modified Eagle's medium, DMEM • extracellular matrix, ECM • epidermal growth factor, EGF • epidermal growth factor receptor, EGF-R • fetal calf serum, FCS • fibroblast growth factor, FGF • leukotriene D4, LTD4 • reverse transcriptase–polymerase chain reaction, RT-PCR • sodium dodecyl sulfate–polyacrylamide gel electrophoresis, SDS-PAGE